Eisai
4523.T
#1978
Rank
NZ$14.25 B
Marketcap
$50.56
Share price
0.73%
Change (1 day)
-28.09%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.82. In 2022 the company made an earnings per share (EPS) of $2.81 a decrease over its 2021 EPS that were of $12.46.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5426.16%
2022$2.81-77.48%
2021$12.46-41.88%
2020$21.43-0.94%
2019$21.6452.59%
2018$14.18124.17%
2017$6.33-49.42%
2016$12.5137.08%
2015$9.12-11.75%
2014$10.34-3.23%
2013$10.68-18.56%
2012$13.12-15.51%
2011$15.53-3.75%
2010$16.13-1.36%
2009$16.36